Vincent Gerusz

428 total citations
9 papers, 284 citations indexed

About

Vincent Gerusz is a scholar working on Molecular Biology, Genetics and Infectious Diseases. According to data from OpenAlex, Vincent Gerusz has authored 9 papers receiving a total of 284 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Genetics and 3 papers in Infectious Diseases. Recurrent topics in Vincent Gerusz's work include Bacterial Genetics and Biotechnology (4 papers), Antibiotic Resistance in Bacteria (3 papers) and Bacteriophages and microbial interactions (2 papers). Vincent Gerusz is often cited by papers focused on Bacterial Genetics and Biotechnology (4 papers), Antibiotic Resistance in Bacteria (3 papers) and Bacteriophages and microbial interactions (2 papers). Vincent Gerusz collaborates with scholars based in Austria, Canada and United Kingdom. Vincent Gerusz's co-authors include Sonia Escaich, Vanida Vongsouthi, F. Moreau, Stéphanie Floquet, Alexis Denis, Lionel Durant, Nicolas Desroy, Kristina Wolf, F. Moreau and Laure Prouvensier and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and Chemistry - A European Journal.

In The Last Decade

Vincent Gerusz

9 papers receiving 275 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vincent Gerusz Austria 6 166 109 49 30 30 9 284
Vanida Vongsouthi Germany 6 168 1.0× 120 1.1× 54 1.1× 29 1.0× 38 1.3× 6 293
Jamie M. Froelich United States 8 145 0.9× 205 1.9× 46 0.9× 23 0.8× 78 2.6× 10 356
Craig Muldoon Australia 8 117 0.7× 120 1.1× 91 1.9× 85 2.8× 28 0.9× 9 301
Christian Fetzer Germany 9 71 0.4× 154 1.4× 44 0.9× 40 1.3× 43 1.4× 15 285
Manica Müller‐Premru Slovenia 7 62 0.4× 126 1.2× 48 1.0× 19 0.6× 50 1.7× 7 222
Brian V. Falcone United States 4 119 0.7× 264 2.4× 37 0.8× 50 1.7× 89 3.0× 6 339
Stona R. Jackson United States 7 120 0.7× 120 1.1× 72 1.5× 23 0.8× 66 2.2× 9 360
Kimberly D. Grimes United States 8 85 0.5× 224 2.1× 30 0.6× 65 2.2× 59 2.0× 9 354
Stephen M. Hammond United Kingdom 6 143 0.9× 166 1.5× 34 0.7× 26 0.9× 45 1.5× 8 310
Kelly Fahnoe United States 4 45 0.3× 92 0.8× 80 1.6× 34 1.1× 38 1.3× 5 223

Countries citing papers authored by Vincent Gerusz

Since Specialization
Citations

This map shows the geographic impact of Vincent Gerusz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Gerusz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Gerusz more than expected).

Fields of papers citing papers by Vincent Gerusz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Gerusz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Gerusz. The network helps show where Vincent Gerusz may publish in the future.

Co-authorship network of co-authors of Vincent Gerusz

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent Gerusz. A scholar is included among the top collaborators of Vincent Gerusz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent Gerusz. Vincent Gerusz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Kosma, Paul, Markus Blaukopf, Dmytro Atamanyuk, Nuno M. Xavier, & Vincent Gerusz. (2017). Synthesis of 1,5-Anhydro-d-glycero-d-gluco-heptitol Derivatives as Potential Inhibitors of Bacterial Heptose Biosynthetic Pathways. Synthesis. 49(24). 5320–5334. 2 indexed citations
2.
Desroy, Nicolas, Alexis Denis, Dmytro Atamanyuk, et al.. (2013). Novel HldE-K Inhibitors Leading to Attenuated Gram Negative Bacterial Virulence. Journal of Medicinal Chemistry. 56(4). 1418–1430. 23 indexed citations
3.
Atamanyuk, Dmytro, et al.. (2013). Vectorization Efforts To Increase Gram-Negative Intracellular Drug Concentration: A Case Study on HldE-K Inhibitors. Journal of Medicinal Chemistry. 56(5). 1908–1921. 4 indexed citations
4.
Atamanyuk, Dmytro, Nicolas Desroy, Alexis Denis, et al.. (2012). Structural–Functional Studies of Burkholderia cenocepacia d-Glycero-β-d-manno-heptose 7-Phosphate Kinase (HldA) and Characterization of Inhibitors with Antibiotic Adjuvant and Antivirulence Properties. Journal of Medicinal Chemistry. 56(4). 1405–1417. 15 indexed citations
5.
Durka, Maxime, Abdellatif Tikad, Michaël Bosco, et al.. (2011). Systematic Synthesis of Inhibitors of the Two First Enzymes of the Bacterial Heptose Biosynthetic Pathway: Towards Antivirulence Molecules Targeting Lipopolysaccharide Biosynthesis. Chemistry - A European Journal. 17(40). 11305–11313. 39 indexed citations
6.
Escaich, Sonia, Laure Prouvensier, Lionel Durant, et al.. (2011). The MUT056399 Inhibitor of FabI Is a New Antistaphylococcal Compound. Antimicrobial Agents and Chemotherapy. 55(10). 4692–4697. 58 indexed citations
7.
Moreau, F., Lionel Durant, Alexis Denis, et al.. (2010). Towards Gram-positive antivirulence drugs: New inhibitors of Streptococcus agalactiae Stk1. Bioorganic & Medicinal Chemistry Letters. 20(12). 3486–3490. 5 indexed citations
8.
Desroy, Nicolas, F. Moreau, Stéphanie Floquet, et al.. (2008). Towards Gram-negative antivirulence drugs: New inhibitors of HldE kinase. Bioorganic & Medicinal Chemistry. 17(3). 1276–1289. 66 indexed citations
9.
Moreau, F., Nicolas Desroy, Vanida Vongsouthi, et al.. (2008). Discovery of new Gram-negative antivirulence drugs: Structure and properties of novel E. coli WaaC inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(14). 4022–4026. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vanida Vongsouthi Breakdown of academic impact, for papers by Jamie M. Froelich Breakdown of academic impact, for papers by Craig Muldoon Breakdown of academic impact, for papers by Christian Fetzer Breakdown of academic impact, for papers by Manica Müller‐Premru Breakdown of academic impact, for papers by Brian V. Falcone Breakdown of academic impact, for papers by Stona R. Jackson Breakdown of academic impact, for papers by Kimberly D. Grimes Breakdown of academic impact, for papers by Stephen M. Hammond Breakdown of academic impact, for papers by Kelly Fahnoe
Rankless by CCL
2026